108 related articles for article (PubMed ID: 4687467)
1. Malignant melanoma: a case report.
Arena PJ
J Ky Med Assoc; 1973 Feb; 71(2):84-6. PubMed ID: 4687467
[No Abstract] [Full Text] [Related]
2. Malignant melanoma.
Moore GE; Gerner RE
Surg Gynecol Obstet; 1971 Mar; 132(3):427-36. PubMed ID: 5546295
[No Abstract] [Full Text] [Related]
3. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
4. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
5. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.
Einhorn LH; Burgess MA; Vallejos C; Bodey GP; Gutterman J; Mavligit G; Hersh EM; Luce JK; Frei E; Freireich EJ; Gottlieb JA
Cancer Res; 1974 Aug; 34(8):1995-2004. PubMed ID: 4842252
[No Abstract] [Full Text] [Related]
6. [Malignant melanoma: local perfusions].
Pettavel J
Pathol Biol (Paris); 1990 Oct; 38(8):870-1. PubMed ID: 2274394
[No Abstract] [Full Text] [Related]
7. Advances in the treatment of malignant melanoma.
Krementz ET; Creach O
Proc Natl Cancer Conf; 1970; 6():529-42. PubMed ID: 5458120
[No Abstract] [Full Text] [Related]
8. Use of sargramostim as maintenance therapy in patients with stage IV melanoma at high risk for systemic recurrence.
Hemrajani RH; Kim KB; Amos WR; Mann DE
Melanoma Res; 2007 Aug; 17(4):257-9. PubMed ID: 17625458
[No Abstract] [Full Text] [Related]
9. Melanoma vaccines: possible progress after years of frustration?
Schmidt C
J Natl Cancer Inst; 2009 Feb; 101(3):140-1. PubMed ID: 19176461
[No Abstract] [Full Text] [Related]
10. Emerging therapies for melanoma.
Katipamula R; Markovic SN
Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
[TBL] [Abstract][Full Text] [Related]
11. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB
Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815
[No Abstract] [Full Text] [Related]
12. The systemic treatment of advanced cutaneous melanoma.
Logan TF
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
[No Abstract] [Full Text] [Related]
13. Dual fronts poised to transform melanoma therapy.
Mullard A
Nat Rev Drug Discov; 2011 May; 10(5):325-6. PubMed ID: 21532549
[No Abstract] [Full Text] [Related]
14. Immunotherapy of malignant melanoma.
Roenigk HH
Compr Ther; 1975 Aug; 1(4):65-70. PubMed ID: 1220917
[No Abstract] [Full Text] [Related]
15. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
Berman E; Casper ES; Howard J; Wittes RE
Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy for metastatic melanoma.
Amaravadi RK; Flaherty KT
Clin Adv Hematol Oncol; 2007 May; 5(5):386-94. PubMed ID: 17673894
[No Abstract] [Full Text] [Related]
17. Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance.
Koon HB; Atkins MB
Expert Rev Anticancer Ther; 2007 Jan; 7(1):79-88. PubMed ID: 17187522
[TBL] [Abstract][Full Text] [Related]
18. Melanoma.
Benson C; Gore ME
Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036
[No Abstract] [Full Text] [Related]
19. [Chemotherapy of malignant melanoma].
Veronesi U; Bajetta E
Cancro; 1973; 26(5):307-13. PubMed ID: 4793832
[No Abstract] [Full Text] [Related]
20. [On some morphological and clinical aspects of malignant melanomas of the skin].
Aletti L; Bologna A; Rosso PA
Minerva Chir; 1969 Apr; 24(8):443-50. PubMed ID: 5785044
[No Abstract] [Full Text] [Related]
[Next] [New Search]